JPMorgan Chase & Co’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.4M Buy
2,261,793
+1,402,737
+163% +$38.7M ﹤0.01% 1094
2025
Q1
$24.4M Buy
859,056
+335,879
+64% +$9.52M ﹤0.01% 1568
2024
Q4
$21.8M Sell
523,177
-1,703,867
-77% -$70.8M ﹤0.01% 1688
2024
Q3
$149M Buy
2,227,044
+470,336
+27% +$31.4M 0.01% 745
2024
Q2
$209M Buy
1,756,708
+315,268
+22% +$37.4M 0.02% 602
2024
Q1
$154M Sell
1,441,440
-1,087,231
-43% -$116M 0.01% 697
2023
Q4
$251M Sell
2,528,671
-52,885
-2% -$5.26M 0.02% 510
2023
Q3
$267M Buy
2,581,556
+166,182
+7% +$17.2M 0.03% 439
2023
Q2
$293M Buy
2,415,374
+531,790
+28% +$64.6M 0.03% 432
2023
Q1
$289M Buy
1,883,584
+1,089,003
+137% +$167M 0.04% 402
2022
Q4
$143M Buy
794,581
+103,009
+15% +$18.5M 0.02% 588
2022
Q3
$81.8M Sell
691,572
-446,785
-39% -$52.8M 0.01% 751
2022
Q2
$163M Buy
1,138,357
+75,202
+7% +$10.7M 0.02% 537
2022
Q1
$183M Sell
1,063,155
-5,514
-0.5% -$950K 0.02% 556
2021
Q4
$271M Sell
1,068,669
-209,082
-16% -$53.1M 0.03% 460
2021
Q3
$492M Sell
1,277,751
-210,229
-14% -$80.9M 0.06% 296
2021
Q2
$350M Sell
1,487,980
-803,573
-35% -$189M 0.04% 414
2021
Q1
$300M Sell
2,291,553
-333,959
-13% -$43.7M 0.04% 426
2020
Q4
$274M Buy
2,625,512
+376,621
+17% +$39.3M 0.04% 413
2020
Q3
$159M Buy
2,248,891
+568,761
+34% +$40.1M 0.03% 508
2020
Q2
$108M Sell
1,680,130
-757,315
-31% -$48.6M 0.02% 598
2020
Q1
$73M Buy
2,437,445
+104,567
+4% +$3.13M 0.02% 637
2019
Q4
$45.6M Buy
2,332,878
+266,191
+13% +$5.21M 0.01% 907
2019
Q3
$32.9M Sell
2,066,687
-1,045,343
-34% -$16.6M 0.01% 1071
2019
Q2
$44.6M Buy
3,112,030
+1,675,790
+117% +$24M 0.01% 922
2019
Q1
$29.2M Sell
1,436,240
-46,970
-3% -$956K 0.01% 1118
2018
Q4
$22.6M Buy
+1,483,210
New +$22.6M 0.01% 1192